López-Marte, P.; Soto-González, A.; Ramos-Tollinchi, L.; Torres-Jorge, S.; Ferre, M.; RodrÃguez-Martinó, E.; Torres, E.A.; Sariol, C.A.
Inefficient Induction of Neutralizing Antibodies against SARS-CoV-2 Variants in Patients with Inflammatory Bowel Disease on Anti-Tumor Necrosis Factor Therapy after Receiving a Third mRNA Vaccine Dose. Vaccines 2022, 10, 1301.
https://doi.org/10.3390/vaccines10081301
AMA Style
López-Marte P, Soto-González A, Ramos-Tollinchi L, Torres-Jorge S, Ferre M, RodrÃguez-Martinó E, Torres EA, Sariol CA.
Inefficient Induction of Neutralizing Antibodies against SARS-CoV-2 Variants in Patients with Inflammatory Bowel Disease on Anti-Tumor Necrosis Factor Therapy after Receiving a Third mRNA Vaccine Dose. Vaccines. 2022; 10(8):1301.
https://doi.org/10.3390/vaccines10081301
Chicago/Turabian Style
López-Marte, Paola, Alondra Soto-González, Lizzie Ramos-Tollinchi, Stephan Torres-Jorge, Mariana Ferre, Esteban RodrÃguez-Martinó, Esther A. Torres, and Carlos A. Sariol.
2022. "Inefficient Induction of Neutralizing Antibodies against SARS-CoV-2 Variants in Patients with Inflammatory Bowel Disease on Anti-Tumor Necrosis Factor Therapy after Receiving a Third mRNA Vaccine Dose" Vaccines 10, no. 8: 1301.
https://doi.org/10.3390/vaccines10081301
APA Style
López-Marte, P., Soto-González, A., Ramos-Tollinchi, L., Torres-Jorge, S., Ferre, M., RodrÃguez-Martinó, E., Torres, E. A., & Sariol, C. A.
(2022). Inefficient Induction of Neutralizing Antibodies against SARS-CoV-2 Variants in Patients with Inflammatory Bowel Disease on Anti-Tumor Necrosis Factor Therapy after Receiving a Third mRNA Vaccine Dose. Vaccines, 10(8), 1301.
https://doi.org/10.3390/vaccines10081301
